Current Pharmaceutical Biotechnology

Papers
(The H4-Index of Current Pharmaceutical Biotechnology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Acknowledgement to Reviewers88
Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis50
Tryptophan Stability and Palatability in the Food Formulation: A Review49
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders49
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders46
An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles46
Nerolidol-potential Therapeutic Agent for Various Neurological Disorders via its Antioxidative Property44
Protective Role of Glibenclamide and Magnesium Sulfate in Fructoseinduced Type 2 Diabetes Mellitus35
A Review on Edible Vaccines and Biopharmaceutical Products from Plants35
Corrigendum to: The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials35
Spray Drying: A Promising Technique for Inhalable Vaccine Development33
Review on Natural Bioactive Products as Radioprotective Therapeutics: Present and Past Perspective33
Potential Pathogens Associated with Colorectal Cancer29
Polygonati Rhizoma Alleviates Vascular Dementia through Regulating Microglial Polarization Transitions Mediated by NF-κB/NLRP3 Pathway28
Pharmacological Action and Research Progress of Taraxasterol27
Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges27
FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges26
Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics25
Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer25
Hydrogel Breakthroughs in Biomedicine: Recent Advances and Implications25
WITHDRAWN: Current Synopsis on siRNA Therapeutics as a Novel Anti- Cancer and Antiviral Strategy: Progress and Challenges24
Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a Novel 2-phenylquinazolinone Derivative in Cancer Therapy- An In-silico Investigation Thera23
Molecular Mechanisms of Immune Resistance in Pancreatic Cancer:An Update23
Nanogels as Drug Delivery Carrier: A Narrative Review on Formulation Techniques, Characterization, Applications and Patents23
Research Progress on the Effect and Mechanism of Gene Transfection in Reducing the Inflammatory Response of Atherosclerosis23
Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate Via NF-κB/NLRP3 Signaling Pathway23
0.15797686576843